CD274 and neoplasm: For some PD-1/PD-L1 ICIs, as a companion diagnostic, PD-L1 IHC conditions the possibility to use the treatment itself or provide its use in a first-line of treatment if the tumor sample sufficiently expresses the PD-L1 molecule.